As President of the Innovative Medicines US unit for Novartis, Victor Bulto is pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.Victor is driven by the pressing need to translate medicines to outcomes – at scale and equitably – and transform the patient experience to help mitigate the challenges people living with disease face in getting diagnosed, obtaining medicine, and staying on treatment within the complex US healthcare system."We have a duty to do better for patients...read more